Q2 2024 Holdings
Filed 2024-08-14 | 74 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $302.7K | 418,208 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $396.3K | 99,313 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $455.9K | 199,963 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $827.9K | 61,277 | 0.1% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $907.2K | 166,460 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $948.4K | 152,965 | 0.1% |
| Absci Corporation(ABSI) | COM | 00091E109 | $1.0M | 325,509 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.5M | 72,317 | 0.1% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.8M | 496,171 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.9M | 286,266 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.1M | 610,902 | 0.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $2.2M | 91,907 | 0.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.5M | 92,909 | 0.2% |
| Alector Inc(ALEC) | COM | 014442107 | $2.5M | 541,739 | 0.2% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $2.6M | 12,178 | 0.2% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $2.6M | 204,781 | 0.2% |
| Avantor Inc(AVTR) | COM | 05352A100 | $2.7M | 125,394 | 0.2% |
| Inflarx NV(IFRX) | COM | N44821101 | $2.7M | 1,566,930 | 0.2% |
| Guardant Health Inc(GH) | COM | 40131M109 | $2.9M | 99,377 | 0.2% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $3.0M | 4,308,527 | 0.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.1M | 71,596 | 0.2% |
| Merus N V | COM | N5749R100 | $3.9M | 66,474 | 0.3% |
| Icon PLC(ICLR) | SHS | G4705A100 | $4.0M | 12,642 | 0.3% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $4.2M | 499,395 | 0.3% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $4.3M | 1,107,743 | 0.3% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $4.3M | 4,987,180 | 0.3% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $4.3M | 1,328,454 | 0.3% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $4.5M | 181,961 | 0.3% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $4.5M | 373,554 | 0.3% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $4.5M | 110,010 | 0.3% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $4.9M | 310,893 | 0.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.9M | 5,484,148 | 0.3% |
| Sutro Biopharma Inc | COM | 869367102 | $5.1M | 1,739,129 | 0.3% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $5.4M | 18,277 | 0.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $6.2M | 574,462 | 0.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $6.3M | 329,890 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.9M | 126,877 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $7.1M | 1,152,573 | 0.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.3M | 96,089 | 0.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $7.3M | 138,489 | 0.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $7.4M | 567,487 | 0.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $7.7M | 115,820 | 0.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $7.8M | 837,847 | 0.5% |
| Elevance Health Inc(ELV) | COM | 036752103 | $7.9M | 14,657 | 0.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $9.0M | 1,091,165 | 0.6% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $9.3M | 100,000 | 0.6% |
| Danaher Corporation(DHR) | COM | 235851102 | $10.2M | 40,855 | 0.7% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $10.6M | 1,546,842 | 0.7% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $11.8M | 2,256,952 | 0.8% |
| Zimvie Inc(ZIMV) | COM | 98888T107 | $14.0M | 767,659 | 1.0% |